Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Predictive Biomarkers In Selecting Patient Populations For I-O Treatment In RCC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.
http://obroncology.com